Team Metabolic Health

Weight-loss drugs, particularly newer options like GLP-1 receptor agonists, are revolutionising the treatment of obesity and metabolic diseases such as diabetes and cardiovascular disorders. Hailed for their efficacy, these drugs are helping patients lose significant weight and offer additional health benefits. Experts see them as game-changers in the way some of the chronic conditions are managed by doctors. Caution is however advised to prevent their misuse and dependency. While the medications could complement lifestyle changes and even eliminate the need of bariatric surgery, accessibility and long-term effects remain concerns. Balancing life-changing innovations with responsible use are the key to maximising their positive impact on health.

Credit: ET World